NCT05912647 Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
| NCT ID | NCT05912647 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Wisconsin, Madison |
| Condition | Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 376 participants |
| Start Date | 2024-02-03 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 376 participants in total. It began in 2024-02-03 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management. This research is being done because we want to improve use of medicines and diabetes management among adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for adults. Participants will be assigned to one of 4 groups, and will either: * receive care as usual; or, * receive added medicine management support from a pharmacist; or, * receive support from a Community Health Worker (CHW) to address life challenges; or, * receive both the pharmacist medicine management and the CHW support
Eligibility Criteria
Inclusion Criteria: * Men and women ages 18-90 with diagnosed type 2 diabetes who speak and understand English or Spanish. * Taking at least one oral or injectable diabetes medication * HbA1c ≥ 7.5% based on point of care test. * Will reside in the geographical area throughout the study period. * Have access to a phone during the study period. * Willing to attend all orientation/training sessions. Exclusion Criteria: * Having a caregiver who is the main decision maker in self-management. * Participating in another lifestyle, or medication adherence program. * Participated in standard MTM/MTM-related intervention in the last 6 months. * Women who are pregnant or plan to get pregnant in the next 6 months.
Contact & Investigator
Michelle Chui, PharmD, PhD
PRINCIPAL INVESTIGATOR
University of Wisconsin, Madison
Frequently Asked Questions
Who can join the NCT05912647 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05912647 currently recruiting?
Yes, NCT05912647 is actively recruiting participants. Contact the research team at mamaurer@wisc.edu for enrollment information.
Where is the NCT05912647 trial being conducted?
This trial is being conducted at Madison, United States.
Who is sponsoring the NCT05912647 clinical trial?
NCT05912647 is sponsored by University of Wisconsin, Madison. The principal investigator is Michelle Chui, PharmD, PhD at University of Wisconsin, Madison. The trial plans to enroll 376 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.